NeuroOne Medical Technologies Corporation (NMTC) Return on equity 2021–2025
NeuroOne Medical Technologies Corporation (NMTC) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-51.0%FY2025 · since FY2021: -151.8% → -51.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -51.0% | +1447.6 pp |
| FY2024 | -1498.5% | -1308.8 pp |
| FY2023 | -189.8% | -85.7 pp |
| FY2022 | -104.1% | +47.7 pp |
| FY2021 | -151.8% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice